Protocol Review and Monitoring
Protocol Review and Monitoring
批准号:
7944595
负责人:
STEVEN P STRATTON
金额:
$7.56万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-08-19 至 2014-06-30
关键词:
ArizonaAuthorization documentationBasic ScienceBehavioralCancer CenterCancer Center Support GrantCaringChairpersonClinicalClinical ResearchConsentDiagnosticDisciplineEnsureFacultyGrantGynecologic OncologyHematologyLaboratoriesMalignant NeoplasmsMedicalMonitorNaturePatientsPediatric Hematology/OncologyPeer ReviewPerformanceProtocols documentationRecordsResearchResearch Ethics CommitteesResearch PersonnelResource SharingReview CommitteeSamplingServicesSurgical OncologySystemTherapeuticTranslational ResearchTreatment ProtocolsUnited States National Institutes of HealthUniversitiesWritingbasecancer chemopreventioncancer therapydesignmemberoncologypopulation basedresearch study
中文摘要
9.2协议审查和监测系统(PRMS)
英文摘要
9.2 Protocol Review and Monitoring System (PRMS)
The Protocol Review and Monitoring System at the Arizona Cancer Center facilitates the our Scientific Review
Committee (SRC), which is staffed with appropriate faculty and scientific representation in all disiciplines, to
include but not be limited to medical hematology/oncology, surgical oncology, gynecologic oncology, radiafion
oncology, pediatric hematology/oncology. Other medical subspecialities, cancer chemoprevention, and,
translationals studies with clinical and basic science collaborators are also covered.
The primary responsibilities of the AZCC SRC include the following:
¿ Review of all new hypothesis-generated interventional protocols of diagnostic or therapeutic nature as
well as longitudinal population-based studies involving patients, patient samples, or patient records
conducted by AZCC members to ensure the highest scientific quality of clinical research in advance of
IRB submission.
¿ Review ongoing progress of protocols conducted by AZCC members to maximize scientific validity,
assure timely and effective performance.
- ¿ Evaluate the merit of eligible protocols for utilization of AZCC shared resources/services based upon
objective scientific review.
¿ Promote unified standards for protocol implementation and translational research among AZCC
investigators of various disciplines involved in cancer treatment and care.
Regardless of the protocol type, no clinical research study eligible for SRC review can be submitted to the
institutional IRB until SRC approval is granted. SRC actions and approval will accompany IRB submissions. In
exceptional circumstances, concurrent IRB review may be allowed with written permission from the SRC
Chairman.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Translational Studies and Clinical Pharmacology of New Drugs for Chemoprevention
-
批准号:8689936
-
项目类别:
-
资助金额:$5.18万
-
财政年份:2013
-
负责人:STEVEN P STRATTON
-
依托单位:
Core--Drug Development
-
批准号:6991771
-
项目类别:
-
资助金额:$20.82万
-
财政年份:2004
-
负责人:STEVEN P STRATTON
-
依托单位:
MOLECULAR CHEMOPREVENTION MECHANISMS OF TEA POLYPHENOLS
-
批准号:6378120
-
项目类别:
-
资助金额:$11.01万
-
财政年份:2000
-
负责人:STEVEN P STRATTON
-
依托单位:
MOLECULAR CHEMOPREVENTION MECHANISMS OF TEA POLYPHENOLS
-
批准号:6845717
-
项目类别:
-
资助金额:$5.66万
-
财政年份:2000
-
负责人:STEVEN P STRATTON
-
依托单位:
MOLECULAR CHEMOPREVENTION MECHANISMS OF TEA POLYPHENOLS
-
批准号:6614436
-
项目类别:
-
资助金额:$11.64万
-
财政年份:2000
-
负责人:STEVEN P STRATTON
-
依托单位:
MOLECULAR CHEMOPREVENTION MECHANISMS OF TEA POLYPHENOLS
-
批准号:6522846
-
项目类别:
-
资助金额:$5.66万
-
财政年份:2000
-
负责人:STEVEN P STRATTON
-
依托单位:
MOLECULAR CHEMOPREVENTION MECHANISMS OF TEA POLYPHENOLS
-
批准号:6192184
-
项目类别:
-
资助金额:$10.65万
-
财政年份:2000
-
负责人:STEVEN P STRATTON
-
依托单位:
MOLECULAR CHEMOPREVENTION MECHANISMS OF TEA POLYPHENOLS
-
批准号:6696358
-
项目类别:
-
资助金额:$11.98万
-
财政年份:2000
-
负责人:STEVEN P STRATTON
-
依托单位:
Translational Studies and Clinical Pharmacology of New Drugs for Chemoprevention
-
批准号:8059921
-
项目类别:
-
资助金额:$24.54万
-
财政年份:1996
-
负责人:STEVEN P STRATTON
-
依托单位:
Protocol Review and Monitoring
-
批准号:8077350
-
项目类别:
-
资助金额:$7.92万
-
财政年份:--
-
负责人:STEVEN P STRATTON
-
依托单位:
Translational Studies and Clinical Pharmacology of New Drugs for Chemoprevention
-
批准号:8504916
-
项目类别:
-
资助金额:$0.85万
-
财政年份:--
-
负责人:STEVEN P STRATTON
-
依托单位:
Translational Studies and Clinical Pharmacology of New Drugs for Chemoprevention of Skin Cancer
-
批准号:8914949
-
项目类别:
-
资助金额:$26.68万
-
财政年份:--
-
负责人:STEVEN P STRATTON
-
依托单位:
Protocol Review and Monitoring
-
批准号:8377812
-
项目类别:
-
资助金额:$7.12万
-
财政年份:--
-
负责人:STEVEN P STRATTON
-
依托单位:
Translational Studies and Clinical Pharmacology of New Drugs for Chemoprevention of Skin Cancer
-
批准号:8689923
-
项目类别:
-
资助金额:$29.47万
-
财政年份:--
-
负责人:STEVEN P STRATTON
-
依托单位:
Protocol Review and Monitoring
-
批准号:8540967
-
项目类别:
-
资助金额:$6.6万
-
财政年份:--
-
负责人:STEVEN P STRATTON
-
依托单位:
Translational Studies and Clinical Pharmacology of New Drugs for Chemoprevention
-
批准号:8378073
-
项目类别:
-
资助金额:$26.86万
-
财政年份:--
-
负责人:STEVEN P STRATTON
-
依托单位:
Protocol Review and Monitoring
-
批准号:8279430
-
项目类别:
-
资助金额:$3.15万
-
财政年份:--
-
负责人:STEVEN P STRATTON
-
依托单位:
Translational Studies and Clinical Pharmacology of New Drugs for Chemoprevention
-
批准号:8504934
-
项目类别:
-
资助金额:$25.19万
-
财政年份:--
-
负责人:STEVEN P STRATTON
-
依托单位:
Translational Studies and Clinical Pharmacology of New Drugs for Chemoprevention
-
批准号:8533368
-
项目类别:
-
资助金额:$0.67万
-
财政年份:--
-
负责人:STEVEN P STRATTON
-
依托单位:
海外基金